CROSSJECT Aktie
| 1,96EUR | -0,09EUR | -4,25% |
WKN DE: A1XEH4 / ISIN: FR0011716265
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 94 | 101 | 110 | 108 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,01 | 0,01 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 13 | 14 | 11 | 16 | 15 |
| Summe Anlagevermögen | 18 | 19 | 18 | 16 | 15 |
| Summe Aktiva | 32 | 33 | 29 | 32 | 30 |
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 38 | 31 | 35 | 35 | 35 |
| Summe Eigenkapital | -6 | 2 | -6 | -4 | -5 |
| Summe Passiva | 32 | 33 | 29 | 32 | 30 |
Adresse
| 6, rue Pauline Kergomard, 21000 Dijon | |
| Telefon | +33 (3) 80-54-98-50 |
| Internet | http://www.crossject.com |
Management
|
Daniel Gedeon Teper
Member-Supervisory Board |
|
Eric Nemeth
Member-Supervisory Board |
|
Isabelle Liebschütz
Chief Quality & Regulatory Officer |
|
Jean-Francois Loumeau
Member-Supervisory board |
|
Olivier Giré
Chief Operating Officer-Specialty Pharma |
|
Patrick Alexandre
Chairman-Executive Board & Chief Executive Officer |
|
Philippe Monnot
Chairman-Supervisory Board |
|
Tony C. Tipton
Chief Operating Officer-United States |
|
Yannick Plétan
Member-Supervisory Board |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.